Background*

Dr. David N. Chernoff, MD, serves as an Acting Chief Medical Officer at Adamas Pharmaceuticals, Inc. Dr. Chernoff served as Chief Medical Officer of Schiff Nutrition International Inc. since June 2011. Dr. Chernoff has been Senior Vice President of Medical Affairs at Crescendo Bioscience, Inc. since June 2012 and served as its Chief Medical Officer until June 2012. Dr. Chernoff served as Chief Medical Officer at Aquinox Pharmaceuticals Inc. and Adamas Pharmaceuticals ... Inc. Dr. Chernoff served as Chief Medical Officer at Pulse Health LLC. He served as Vice President of Medical Affairs at Adamas Pharmaceuticals, Inc. since September 2005 and also served as its Senior Advisor of Medical Affairs. Dr. Chernoff trained in internal medicine at UCSF and was Assistant Chief of Medicine. From 1990 to 2000, he served as Medical Director of Chiron Corperation/Chiron Diagnostics, playing a pivotal role in the development of assays for HIV, HCV, HBV, and CMV. Dr. Chernoff served as Senior Advisor of Medical Affairs at Adamas Pharmaceuticals Inc. and served as its Vice President of Medical Affairs since September 2005. He served at Elan as Vice President of Corporate Technology, where he led the evaluation of a broad range of in-licensing opportunities. He spent two years as an Entrepreneur-in-Residence and one year as an operating partner at the venture firm TPG, where he was actively involved in due diligence and in incubating new companies. He has been the acting Chief Medical Officer of several startup biotech companies including XDX, CardioDx, Replidyne, Tethys Biosciences, Neuromolecular Pharmaceuticals. He serves as Member of Scintific Advisory Board at Tobira Therapeutics, Inc. He serves as a Member of the Clinical Advisory Board at Inimex Pharmaceuticals, Inc. He has lectured broadly and published dozens of peer-reviewed articles. Dr. Chernoff received a B.S in Biology from Yale University, an M.D. from New York University, and his medical training in internal medicine, rheumatology, and infectious disease at UCSF.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.